These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8032782)

  • 1. [A new Russian phospholipid reagent from soybeans for the study of activated partial thromboplastin time].
    Staritsyna NN; Shanskaia AI; Khrolova PV; Papaian LP
    Klin Lab Diagn; 1993; (6):43-5. PubMed ID: 8032782
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diagnostic value of soybean reagent for determination of activated partial thromboplastin time].
    Shanskaia AI; Staritsyna NN; Khrolova PV; Papaian LP
    Gematol Transfuziol; 1995; 40(5):41-3. PubMed ID: 8566661
    [No Abstract]   [Full Text] [Related]  

  • 3. [Activated partial thromboplastin time].
    Lozano M; Mazzara R
    Med Clin (Barc); 2007 Mar; 128(11):438-9. PubMed ID: 17394861
    [No Abstract]   [Full Text] [Related]  

  • 4. The preparation of a sensitive partial thromboplastin reagent from bovine brain.
    Martin BA; Branch DW; Rodgers GM
    Blood Coagul Fibrinolysis; 1992 Jun; 3(3):287-94. PubMed ID: 1643206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of phospholipid reagents used in coagulation I: some general properties and their sensitivity to factor VIII.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):629-33. PubMed ID: 6797093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of a stable phospholipid reagent for coagulation assays.
    Barrowcliffe TW; Stocks J; Gray E
    Haemostasis; 1982; 11(2):96-101. PubMed ID: 7084814
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics of phospholipids associated with fibrins in partial thromboplastin test.
    Ogawa S; Kurokawa I; Akino T
    Tohoku J Exp Med; 1983 Sep; 141(1):61-9. PubMed ID: 6636150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrophosphatide: a reagent for coagulation studies].
    Rakitianskaia AA; Khomich EN; Gilevskiĭ EN
    Lab Delo; 1982; (1):32-4. PubMed ID: 6174785
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of a photoelectric clot timer in the determination of the activated partial thromboplastin time.
    Davey FR; Oates RP
    Am J Clin Pathol; 1974 Dec; 62(6):851-5. PubMed ID: 4432837
    [No Abstract]   [Full Text] [Related]  

  • 10. The diagnosis of lupus anticoagulants by the activated partial thromboplastin time--the central role of phosphatidyl serine.
    Kelsey PR; Stevenson KJ; Poller L
    Thromb Haemost; 1984 Oct; 52(2):172-5. PubMed ID: 6441303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of synthetic phospholipid in measurement of activated partial thromboplastin time: a new preparation procedure to reduce batch difference.
    Okuda M; Yamamoto Y
    Clin Lab Haematol; 2004 Jun; 26(3):215-23. PubMed ID: 15163321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of fractionated soy phospholipids in a test of activated partial thromboplastin time].
    Staritsyna NN; Shanskaia AI; Puchkova SM; Nedachina NA
    Gematol Transfuziol; 1995; 40(4):36-8. PubMed ID: 7557236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The sensitivity of different coagulation reagents to the presence of lupus anticoagulants.
    Brandt JT; Triplett DA; Musgrave K; Orr C
    Arch Pathol Lab Med; 1987 Feb; 111(2):120-4. PubMed ID: 3101649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults.
    Kamal AH; Tefferi A; Pruthi RK
    Mayo Clin Proc; 2007 Jul; 82(7):864-73. PubMed ID: 17605969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivity of three activated partial thromboplastin time reagents to coagulation factor deficiencies.
    Turi DC; Peerschke EI
    Am J Clin Pathol; 1986 Jan; 85(1):43-9. PubMed ID: 3940420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of reagent batch on activated partial thromboplastin time in canine plasma and use of the ratio system for standardization].
    Mischke R
    Berl Munch Tierarztl Wochenschr; 2002; 115(5-6):225-9. PubMed ID: 12058600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activated partial thromboplastin time in diagnosing coagulation disturbances].
    Nyman D
    Lakartidningen; 1973 Sep; 70(38):3241-2. PubMed ID: 4790458
    [No Abstract]   [Full Text] [Related]  

  • 18. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent.
    Kumano O; Ieko M; Naito S; Yoshida M; Takahashi N
    J Thromb Haemost; 2012 Nov; 10(11):2338-43. PubMed ID: 22909048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of reagents for determining the activated partial thromboplastin time.
    Hoffmann JJ; Meulendijk PN
    Thromb Haemost; 1978 Jun; 39(3):640-5. PubMed ID: 705693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.